FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051152021> ?p ?o ?g. }

• W2051152021 endingPage "203" @default.
• W2051152021 startingPage "197" @default.
• W2051152021 abstract "<b><i>Background:</i></b> The Effect of Cilostazol in Acute Lacunar Infarction Based on Pulsatility Index of the Transcranial Doppler (ECLIPse) study showed a significant decrease in the transcranial Doppler (TCD) pulsatility index (PI) with cilostazol treatment at 90 days after acute lacunar infarction. The aim of the present study was to perform a subgroup analysis of the ECLIPse study in order to explore the effect of cilostazol in acute lacunar infarction based on cerebral white matter hyperintensities (WMH) volume. <b><i>Methods:</i></b> The ECLIPse study was a multicenter, randomized, double-blind, placebo-controlled trial that evaluated the difference between the efficacy of cilostazol and a placebo to reduce the PI in patients with acute lacunar infarction using serial TCD examinations. The primary outcome was changes in the PIs of the middle cerebral artery (MCA) and basilar artery at 14 and 90 days from the baseline TCD study. For this subgroup analysis, using semi-automated computerized software, the WMH volume was measured for those subjects for whom fluid-attenuated inversion recovery (FLAIR) images were available. <b><i>Results:</i></b> Of the 203 patients in eight hospitals in the ECLIPse study, 130 participants from six hospitals were included in this subgroup analysis. Cilostazol was given to 63 patients (48.5%) and placebo to 67 patients (51.5%). All baseline characteristics were well balanced across the two groups, and there were no significant differences in these characteristics except in the changes of PI from the baseline to the 90-day point. There was a significant decrease of TCD PIs at 90-day study from baseline in the cilostazol group (p = 0.02). The mean WMH volume was 11.57 cm³ (0.13-68.45, median 4.86) and the mean MCA PI was 0.95 (0.62-1.50). The changes in PIs from the baseline to 14 days and to 90 days were 0.09 (-0.21 to 0.33) and 0.10 (-0.22 to 0.36). While there were no significant correlations between WMH volume and the changes in PIs, a trend of inverse correlation was observed between the WMH volume and the changes in PIs from the baseline to the 90-day point. For the subgroup analysis, the WMH volume was dichotomized based on its median value (4.90 cm³). Cilostazol decreased the TCD PIs significantly at the 90-day point in patients with WMH volumes ≤4.9 cm³ (p = 0.002). Significant treatment effects were observed in the cilostazol group. <b><i>Conclusions:</i></b> This study showed that cilostazol decreased cerebral arterial pulsatility in patients with WMH. Our findings indicate the unique effect of cilostazol in small vessel disease (SVD), especially in patients with mild WMH changes. Further clinical trials focusing on WMH volume and clinical outcomes are required to assess the unique efficacy of cilostazol in SVD." @default.
• W2051152021 created "2016-06-24" @default.
• W2051152021 creator A5009516655 @default.
• W2051152021 creator A5019240740 @default.
• W2051152021 creator A5033375010 @default.
• W2051152021 creator A5034889878 @default.
• W2051152021 creator A5037543895 @default.
• W2051152021 creator A5049471995 @default.
• W2051152021 creator A5049675779 @default.
• W2051152021 creator A5063123730 @default.
• W2051152021 creator A5063263666 @default.
• W2051152021 creator A5068223700 @default.
• W2051152021 creator A5070426067 @default.
• W2051152021 creator A5074293490 @default.
• W2051152021 creator A5075169325 @default.
• W2051152021 creator A5078190259 @default.
• W2051152021 creator A5079022368 @default.
• W2051152021 creator A5086327938 @default.
• W2051152021 creator A5087073139 @default.
• W2051152021 creator A5087999835 @default.
• W2051152021 date "2014-01-01" @default.
• W2051152021 modified "2023-09-25" @default.
• W2051152021 title "Cilostazol Decreases Cerebral Arterial Pulsatility in Patients with Mild White Matter Hyperintensities: Subgroup Analysis from the Effect of Cilostazol in Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler (ECLIPse) Study" @default.
• W2051152021 cites W1973950885 @default.
• W2051152021 cites W1974740897 @default.
• W2051152021 cites W1981589156 @default.
• W2051152021 cites W1995229944 @default.
• W2051152021 cites W2000179308 @default.
• W2051152021 cites W2054248812 @default.
• W2051152021 cites W2068731335 @default.
• W2051152021 cites W2083691354 @default.
• W2051152021 cites W2088733850 @default.
• W2051152021 cites W2088910052 @default.
• W2051152021 cites W2104901197 @default.
• W2051152021 cites W2119380659 @default.
• W2051152021 cites W2119809681 @default.
• W2051152021 cites W2122477279 @default.
• W2051152021 cites W2127282484 @default.
• W2051152021 cites W2128874197 @default.
• W2051152021 cites W2129052557 @default.
• W2051152021 cites W2133501611 @default.
• W2051152021 cites W2135679272 @default.
• W2051152021 cites W2136363354 @default.
• W2051152021 cites W2140621953 @default.
• W2051152021 cites W2144437121 @default.
• W2051152021 cites W2144971762 @default.
• W2051152021 cites W2158742097 @default.
• W2051152021 cites W2163119611 @default.
• W2051152021 doi "https://doi.org/10.1159/000365840" @default.
• W2051152021 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25300977" @default.
• W2051152021 hasPublicationYear "2014" @default.
• W2051152021 type Work @default.
• W2051152021 sameAs 2051152021 @default.
• W2051152021 citedByCount "25" @default.
• W2051152021 countsByYear W20511520212015 @default.
• W2051152021 countsByYear W20511520212016 @default.
• W2051152021 countsByYear W20511520212017 @default.
• W2051152021 countsByYear W20511520212018 @default.
• W2051152021 countsByYear W20511520212019 @default.
• W2051152021 countsByYear W20511520212020 @default.
• W2051152021 countsByYear W20511520212021 @default.
• W2051152021 countsByYear W20511520212022 @default.
• W2051152021 countsByYear W20511520212023 @default.
• W2051152021 crossrefType "journal-article" @default.
• W2051152021 hasAuthorship W2051152021A5009516655 @default.
• W2051152021 hasAuthorship W2051152021A5019240740 @default.
• W2051152021 hasAuthorship W2051152021A5033375010 @default.
• W2051152021 hasAuthorship W2051152021A5034889878 @default.
• W2051152021 hasAuthorship W2051152021A5037543895 @default.
• W2051152021 hasAuthorship W2051152021A5049471995 @default.
• W2051152021 hasAuthorship W2051152021A5049675779 @default.
• W2051152021 hasAuthorship W2051152021A5063123730 @default.
• W2051152021 hasAuthorship W2051152021A5063263666 @default.
• W2051152021 hasAuthorship W2051152021A5068223700 @default.
• W2051152021 hasAuthorship W2051152021A5070426067 @default.
• W2051152021 hasAuthorship W2051152021A5074293490 @default.
• W2051152021 hasAuthorship W2051152021A5075169325 @default.
• W2051152021 hasAuthorship W2051152021A5078190259 @default.
• W2051152021 hasAuthorship W2051152021A5079022368 @default.
• W2051152021 hasAuthorship W2051152021A5086327938 @default.
• W2051152021 hasAuthorship W2051152021A5087073139 @default.
• W2051152021 hasAuthorship W2051152021A5087999835 @default.
• W2051152021 hasConcept C126322002 @default.
• W2051152021 hasConcept C142724271 @default.
• W2051152021 hasConcept C164705383 @default.
• W2051152021 hasConcept C191616109 @default.
• W2051152021 hasConcept C204787440 @default.
• W2051152021 hasConcept C27081682 @default.
• W2051152021 hasConcept C2775841333 @default.
• W2051152021 hasConcept C2777628954 @default.
• W2051152021 hasConcept C2777798775 @default.
• W2051152021 hasConcept C2779285336 @default.
• W2051152021 hasConcept C2779450755 @default.
• W2051152021 hasConcept C2779820409 @default.
• W2051152021 hasConcept C3020199598 @default.
• W2051152021 hasConcept C42219234 @default.
• W2051152021 hasConcept C500558357 @default.
• W2051152021 hasConcept C541997718 @default.

• next